(Q28202929)

Hepatic artery embolization

inferred from title

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

31 December 2023

2

Sanjay Gupta

1 reference

Europe PubMed Central

PubMed publication ID

12735133

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735133

31 December 2023

author name string

Kamran Ahrar

full work available at URL

1

0 references

language of work or name

English

0 references

publication date

January 2003

0 references

https://api.elsevier.com/content/article/PII:S1055320702000893?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

https://api.elsevier.com/content/article/PII:S1055320702000893?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

Surgical oncology clinics of North America

31 December 2023

published in

0 references

volume

12

0 references

issue

1

0 references

page(s)

105-26

0 references

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatic resection for hepatocellular carcinoma. An audit of 343 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Recurrence of hepatocellular carcinoma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Blood supply of early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatic artery ligation and postoperative chemotherapy for hepatic metastases: Clinical and pathophysiological results

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Angiographic classification of hepatic arterial collaterals

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Proximal versus peripheral hepatic artery embolization experimental study in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Pharmacokinetics of intra-arterial mitomycin C with or without degradable starch microspheres (DSM) in the treatment of non-resectable liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Effects of intraarterial chemotherapy using the new lipophilic anticancer agent 'KM2210' (estradiol-chlorambucil) dissolved in lipiodol on Walker 256 carcinosarcoma in Wistar rats--a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Transcatheter oily chemoembolization of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatocellular carcinoma detected by iodized oil

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Nourishment of hepatocellular carcinoma cells through the portal blood flow with and without transcatheter arterial embolization

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolization: experimental study in several animal species

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Liver parenchymal changes after transcatheter arterial embolization therapy for hepatoma: CT evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Determinants of postembolization syndrome after hepatic chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Chemoembolization of hepatic neoplasms: safety, complications, and when to worry

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Primary treatment of hepatocellular carcinoma by arterial chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Nonresectional therapies for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

The role of hepatic arterial embolization in the management of ruptured hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

The risk of hepatic artery embolization in the presence of obstructive jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatic chemoembolization: safety with portal vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Combined peripheral and central chemoembolization of liver tumors. Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE).

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatocellular carcinoma: efficacy of transcatheter oily chemoembolization in relation to macroscopic and microscopic patterns of tumor growth among 100 patients with partial hepatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Particle embolization for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

A randomized trial of intrahepatic arterial infusion of 4'-epidoxorubicin with Lipiodol versus 4'-epidoxorubicin alone in the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Bile duct necrosis: complication of transcatheter hepatic arterial embolization

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Bile Duct Cysts Secondary to Liver Infarcts: Report of a Case and Experimental Production by Small Vessel Hepatic Artery Occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Prognosis of primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Ethanol injection for the treatment of hepatic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Follow-up study of combination treatment (TAE and PEIT) for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900089-3

7 January 2021

The blood supply of neoplasms in the liver

19

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

Chemoembolization of hepatic malignancies

31 December 2023

32

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

Collagen chemoembolization: pharmacokinetics and tissue tolerance of cis-diamminedichloroplatinum(II) in porcine liver and rabbit kidney

31 December 2023

37

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

Assessment of therapeutic effect of liver tumor ablation procedures

31 December 2023

48

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

Transcatheter hepatic arterial embolization in the treatment of hepatocellular carcinoma

31 December 2023

58

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis

31 December 2023

61

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

Prognostic factors for survival in hepatocellular carcinoma

31 December 2023

92

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma

31 December 2023

97

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00089-3

31 December 2023

Identifiers